Multiple Dose Study to Evaluate the Efficacy, Safety and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus
Clinical trial NCT03117998 · COMPLETED
Trial details
- NCT number
- NCT03117998
- Sponsor
- REMD Biotherapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-19
- Primary completion
- 2021-03-05
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.